Jilin Jian Yisheng Pharmaceutical: Announcement on attending the online group results briefing
Jilin Jian Yisheng Pharmaceutical: Progress Notice on Using Idle Own Funds to Purchase Wealth Management Products
Jilin Jian Yisheng Pharmaceutical: Notice on Using Idle Own Funds to Purchase Wealth Management Products
Jilin Jian Yisheng Pharmaceutical: Announcement of Resolutions of the 13th Meeting of the Eighth Board of Supervisors
Jilin Jian Yisheng Pharmaceutical: Announcement of Resolutions of the 13th Meeting of the Eighth Board of Directors
Jilin Jian Yisheng Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice
Jilin Jian Yisheng Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Jilin Jian Yisheng Pharmaceutical: Legal Opinion of Beijing Zhide Law Firm on the 2023 Annual General Meeting of Shareholders of Jilin Ji'an Yisheng Pharmaceutical Co., Ltd.
Jilin Jian Yisheng Pharmaceutical: 2024 First Quarter Report
Yisheng Pharmaceutical: 002566 Yisheng Pharmaceutical Investor Relations Management Information 20240424
Yisheng Pharmaceutical: Rules of Work for the Nomination Committee of the Board of Directors
Yisheng Pharmaceutical: Annual Special Audit Report on Related Party Capital Occupation
Yisheng Pharmaceutical: Announcement on the 2023 Profit Distribution Plan
Yisheng Pharmaceutical: Independent Director's 2023 Debriefing Report (Xu Shan)
Yisheng Pharmaceutical: 2023 Board Work Report
Yisheng Pharmaceutical: Shareholder return plan for the next three years (2024-2026)
Yisheng Pharmaceutical: 2023 Supervisory Committee Work Report
Yisheng Pharmaceutical: 2023 Annual Audit Report
Yisheng Pharmaceutical: Announcement on holding the 2023 Online Results Briefing
Yisheng Pharmaceutical: Notice of Annual Shareholders' Meeting
No Data